Rgenix Stock

rgenix.comHealthcare / BioTech & PharmaFounded: 2010Funding to Date: $83.5MM

Rgenix is a developer of first-in-class drugs that target key pathways in cancer progression.

Register To Buy and Sell Shares

For more details on financing and valuation for Rgenix, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Rgenix’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Rgenix.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Robert Wasserman MD
Chief Medical Officer
David Darst
Chief Operating Officer & Board Observer
Masoud Tavazoie Ph.D
Co-Founder, Board Member and Chief Executive Officer
Roger Waltzman MD
Chief Medical Officer
Sohail Tavazoie Ph.D
Co-Founder, Scientific & Clinical Advisor
Eric Rowinsky MD
Board Member & President

Board Members

David Darst
Noam Ohana
Conegliano Ventures
Saeed Tavazoie Ph.D
Eric Rowinsky MD
Nilesh Kumar Ph.D
Novo Holdings
Antoine Papiernik
Sofinnova Partners
Masoud Tavazoie Ph.D
Nancy Chang Ph.D
Peter Van Vlasselaer Ph.D

Frequently Asked Questions About Rgenix’s Stock

Can you buy Rgenix’s stock?
Rgenix is not publicly traded on NYSE or NASDAQ in the U.S. To buy Rgenix’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Rgenix’s stock?
Yes, you can sell stock of a private company like Rgenix. Forge can help you sell your Rgenix stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Rgenix’s stock price?
Rgenix is a privately held company and therefore does not have a public stock price. However, you may access Rgenix’s private market stock price with Forge Data.
What is Rgenix’s stock ticker symbol?
Rgenix does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Rgenix Names Industry Veteran to Chief Medical Officer Role
Rgenix, Inc. announced today that industry veteran Robert Wasserman, MD, has joined the Rgenix management team as its new Chief Medical Officer.
Rgenix Raises $40M in Series C Funding To Support Clinical Stage Oncology Programs
Rgenix announces $40 million in a Series C financing in support of further development of the company’s clinical and pre-clinical oncology programs.
Updated on: May 17, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.